Masaya Hattori

Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

Claudia Allemani, Tomohiro Matsuda, V Di Carlo et al. · The Lancet · 2018 · 6.2K citations · Full text

Medicine, Biostatistics, Oncology +17

Worldwide comparison of survival from childhood leukaemia for 1995–2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries

Audrey Bonaventure, Rhea Harewood, Charles Stiller et al. · The Lancet Haematology · 2017 · 215 citations · Full text

Medicine, Oncology, Pediatrics +17

The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR status

Nanae Horisawa, Yayoi Adachi, Daiki Takatsuka et al. · Breast Cancer · 2021 · 213 citations

Medicine, Oncology, Pathology +12

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

Scott E. Kasner, Balakumar Swaminathan, Pablo M. Lavados et al. · The Lancet Neurology · 2018 · 178 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2)

M Matz, Michel P. Coleman, Milena Sant et al. · Gynecologic Oncology · 2016 · 158 citations · Full text

Medicine, Oncology, Pathology +16